Antibiotics are defined as chemical substances that inhibit or limit the growth of microorganisms. Since the second world war, antibiotics have been widely used to reduce the morbidity and mortality associated with serious bacterial infections caused by organisms such as Staphylococcus aureus. However, it has become increasingly difficult to treat bacterial infections due to the emergence of antibiotic resistant strains. The first clinical case of drug resistant bacteria was observed in S. aureus in 1947, just four years after the mass production of penicillin. Since then, resistance has been reported to every antibiotic ever employed. According to the Centres for Disease Control and Prevention of the United States, more than 70% of hospital-acquired infections show resistance to at least one commonly used antibiotic. Coupled with the paucity of therapeutic agents in the pipeline, there is now an urgent demand for new antibiotics. One of the strategies employed to combat drug resistant bacteria requires new chemical entities that work through novel drug targets for which there is no pre-existing resistance. This thesis focuses on the essential metabolic enzyme biotin protein ligase (BPL) as one such new drug target. BPL is the enzyme responsible for covalently attaching the cofactor biotin prosthetic group onto the biotin-dependent enzymes such as the carboxylases, decarboxylases and transcarboxylases. Enzymatic biotinylation proceeds via a two-step reaction whereby biotinyl-5'-AMP is synthesized from biotin and ATP before the biotin moiety is transferred onto the side chain of one specific lysine present in the active site of the biotin-dependent enzyme. One example of an important biotin-dependent enzyme is acetyl CoA carboxylase (ACC). ACC catalyzes the first committed step in fatty acid biosynthesis. Through genetic studies, it has been demonstrated that BPL activity is essential for bacterial survival. The aim for this project was to develop a convenient, high-throughput assay to measure BPL activity. This assay would permit 1) quantitative kinetic analysis of ligands and inhibitors and 2) screening of compound libraries for new BPL inhibitors. We propose that BPL inhibitors can be developed into new antibiotic agents. The novel BPL assay was developed employing fluorescence polarization (FP). FP is a light based technique which uses plane polarized light for the detection of tumbling motion of fluorescent molecules in solution. As polarization of the emitted light is relative to the apparent molecular mass of the fluorophore, this technique can be use for quantitation of changes in molecular mass of target molecules. This enabled 1) rapid kinetic analysis, 2) a minimal number of handling steps, 3) no washing steps and 4) automation by robotics. A first generation assay was developed for Escherichia coli BPL using peptide 85-11 that has been shown to be a convenient substrate. Following the BPL reaction, biotinylated peptides will form large molecular mass complexes with avidin. The amount of product could then be quantitated using FP. Here, kinetic analysis of MgATP (Km 0.25 ± 0.01 mM) and biotin (Km 1.45 ± 0.15 μM) binding produced results consistent with published data. We validated this assay with inhibition studies with end products of the BPL reaction, AMP and pyrophosphate, and a compound, biotinol-5'-AMP. Statistical analysis, performed upon both intraassay and interassay results (n = 30), showed the coefficient of variance to be <10% across all data sets. Furthermore, the Z' factors between 0.5 and 0.8 demonstrated the utility of this technology in high-throughput applications. However, the use of peptide 85-11, a substrate specific to E. coli BPL, does limit the application of this methodology to E. coli. In the second generation FP assay, I adapted this technology for S. aureus BPL by employing the biotin domain of S. aureus pyruvate carboxylase. Insertion of a fluorescein label was achieved by first engineering a cysteine residue into the domain by site directed mutagenesis then incubation with fluorescein-5'-maleimide. A series of mutants was created to investigate optimal positioning of the label into the substrate. Furthermore, the minimal size of the functional domain was determined. Our data showed that the placement of the fluorescein label is an important aspect of this project. Using this approach, I identified that a 90 amino acid domain with the label at position 1134 was optimal. Kinetic analysis of ligand binding showed SaBPL had a Km for biotin at 3.29 ± 0.37 μM and Km for MgATP at 66 ± 16.08 μM. This was in good agreement with data obtained from our previous assay measuring ³H-biotin incorporation. Inhibitor studies with pyrophosphate and analogues of biotin and biotinyl-5'-AMP further validated the assay. Various studies have shown cross-species biotinylation activities by a diverse range of BPLs. Therefore, using this methodology with a biotin domain as the substrate potentially provides a convenient assay for all BPLs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1374330 / Thesis (M.Sc.) -- University of Adelaide, School of Molecular and Biomedical Science, 2009

Antibiotics are defined as chemical substances that inhibit or limit the growth of microorganisms. Since the second world war, antibiotics have been widely used to reduce the morbidity and mortality associated with serious bacterial infections caused by organisms such as Staphylococcus aureus. However, it has become increasingly difficult to treat bacterial infections due to the emergence of antibiotic resistant strains. The first clinical case of drug resistant bacteria was observed in S. aureus in 1947, just four years after the mass production of penicillin. Since then, resistance has been reported to every antibiotic ever employed. According to the Centres for Disease Control and Prevention of the United States, more than 70% of hospital-acquired infections show resistance to at least one commonly used antibiotic. Coupled with the paucity of therapeutic agents in the pipeline, there is now an urgent demand for new antibiotics. One of the strategies employed to combat drug resistant bacteria requires new chemical entities that work through novel drug targets for which there is no pre-existing resistance. This thesis focuses on the essential metabolic enzyme biotin protein ligase (BPL) as one such new drug target. BPL is the enzyme responsible for covalently attaching the cofactor biotin prosthetic group onto the biotin-dependent enzymes such as the carboxylases, decarboxylases and transcarboxylases. Enzymatic biotinylation proceeds via a two-step reaction whereby biotinyl-5'-AMP is synthesized from biotin and ATP before the biotin moiety is transferred onto the side chain of one specific lysine present in the active site of the biotin-dependent enzyme. One example of an important biotin-dependent enzyme is acetyl CoA carboxylase (ACC). ACC catalyzes the first committed step in fatty acid biosynthesis. Through genetic studies, it has been demonstrated that BPL activity is essential for bacterial survival. The aim for this project was to develop a convenient, high-throughput assay to measure BPL activity. This assay would permit 1) quantitative kinetic analysis of ligands and inhibitors and 2) screening of compound libraries for new BPL inhibitors. We propose that BPL inhibitors can be developed into new antibiotic agents. The novel BPL assay was developed employing fluorescence polarization (FP). FP is a light based technique which uses plane polarized light for the detection of tumbling motion of fluorescent molecules in solution. As polarization of the emitted light is relative to the apparent molecular mass of the fluorophore, this technique can be use for quantitation of changes in molecular mass of target molecules. This enabled 1) rapid kinetic analysis, 2) a minimal number of handling steps, 3) no washing steps and 4) automation by robotics. A first generation assay was developed for Escherichia coli BPL using peptide 85-11 that has been shown to be a convenient substrate. Following the BPL reaction, biotinylated peptides will form large molecular mass complexes with avidin. The amount of product could then be quantitated using FP. Here, kinetic analysis of MgATP (Km 0.25 ± 0.01 mM) and biotin (Km 1.45 ± 0.15 μM) binding produced results consistent with published data. We validated this assay with inhibition studies with end products of the BPL reaction, AMP and pyrophosphate, and a compound, biotinol-5'-AMP. Statistical analysis, performed upon both intraassay and interassay results (n = 30), showed the coefficient of variance to be <10% across all data sets. Furthermore, the Z' factors between 0.5 and 0.8 demonstrated the utility of this technology in high-throughput applications. However, the use of peptide 85-11, a substrate specific to E. coli BPL, does limit the application of this methodology to E. coli. In the second generation FP assay, I adapted this technology for S. aureus BPL by employing the biotin domain of S. aureus pyruvate carboxylase. Insertion of a fluorescein label was achieved by first engineering a cysteine residue into the domain by site directed mutagenesis then incubation with fluorescein-5'-maleimide. A series of mutants was created to investigate optimal positioning of the label into the substrate. Furthermore, the minimal size of the functional domain was determined. Our data showed that the placement of the fluorescein label is an important aspect of this project. Using this approach, I identified that a 90 amino acid domain with the label at position 1134 was optimal. Kinetic analysis of ligand binding showed SaBPL had a Km for biotin at 3.29 ± 0.37 μM and Km for MgATP at 66 ± 16.08 μM. This was in good agreement with data obtained from our previous assay measuring ³H-biotin incorporation. Inhibitor studies with pyrophosphate and analogues of biotin and biotinyl-5'-AMP further validated the assay. Various studies have shown cross-species biotinylation activities by a diverse range of BPLs. Therefore, using this methodology with a biotin domain as the substrate potentially provides a convenient assay for all BPLs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1374330 / Thesis (M.Sc.) -- University of Adelaide, School of Molecular and Biomedical Science, 2009

Antibiotics are defined as chemical substances that inhibit or limit the growth of microorganisms. Since the second world war, antibiotics have been widely used to reduce the morbidity and mortality associated with serious bacterial infections caused by organisms such as Staphylococcus aureus. However, it has become increasingly difficult to treat bacterial infections due to the emergence of antibiotic resistant strains. The first clinical case of drug resistant bacteria was observed in S. aureus in 1947, just four years after the mass production of penicillin. Since then, resistance has been reported to every antibiotic ever employed. According to the Centres for Disease Control and Prevention of the United States, more than 70% of hospital-acquired infections show resistance to at least one commonly used antibiotic. Coupled with the paucity of therapeutic agents in the pipeline, there is now an urgent demand for new antibiotics. One of the strategies employed to combat drug resistant bacteria requires new chemical entities that work through novel drug targets for which there is no pre-existing resistance. This thesis focuses on the essential metabolic enzyme biotin protein ligase (BPL) as one such new drug target. BPL is the enzyme responsible for covalently attaching the cofactor biotin prosthetic group onto the biotin-dependent enzymes such as the carboxylases, decarboxylases and transcarboxylases. Enzymatic biotinylation proceeds via a two-step reaction whereby biotinyl-5'-AMP is synthesized from biotin and ATP before the biotin moiety is transferred onto the side chain of one specific lysine present in the active site of the biotin-dependent enzyme. One example of an important biotin-dependent enzyme is acetyl CoA carboxylase (ACC). ACC catalyzes the first committed step in fatty acid biosynthesis. Through genetic studies, it has been demonstrated that BPL activity is essential for bacterial survival. The aim for this project was to develop a convenient, high-throughput assay to measure BPL activity. This assay would permit 1) quantitative kinetic analysis of ligands and inhibitors and 2) screening of compound libraries for new BPL inhibitors. We propose that BPL inhibitors can be developed into new antibiotic agents. The novel BPL assay was developed employing fluorescence polarization (FP). FP is a light based technique which uses plane polarized light for the detection of tumbling motion of fluorescent molecules in solution. As polarization of the emitted light is relative to the apparent molecular mass of the fluorophore, this technique can be use for quantitation of changes in molecular mass of target molecules. This enabled 1) rapid kinetic analysis, 2) a minimal number of handling steps, 3) no washing steps and 4) automation by robotics. A first generation assay was developed for Escherichia coli BPL using peptide 85-11 that has been shown to be a convenient substrate. Following the BPL reaction, biotinylated peptides will form large molecular mass complexes with avidin. The amount of product could then be quantitated using FP. Here, kinetic analysis of MgATP (Km 0.25 ± 0.01 mM) and biotin (Km 1.45 ± 0.15 μM) binding produced results consistent with published data. We validated this assay with inhibition studies with end products of the BPL reaction, AMP and pyrophosphate, and a compound, biotinol-5'-AMP. Statistical analysis, performed upon both intraassay and interassay results (n = 30), showed the coefficient of variance to be <10% across all data sets. Furthermore, the Z' factors between 0.5 and 0.8 demonstrated the utility of this technology in high-throughput applications. However, the use of peptide 85-11, a substrate specific to E. coli BPL, does limit the application of this methodology to E. coli. In the second generation FP assay, I adapted this technology for S. aureus BPL by employing the biotin domain of S. aureus pyruvate carboxylase. Insertion of a fluorescein label was achieved by first engineering a cysteine residue into the domain by site directed mutagenesis then incubation with fluorescein-5'-maleimide. A series of mutants was created to investigate optimal positioning of the label into the substrate. Furthermore, the minimal size of the functional domain was determined. Our data showed that the placement of the fluorescein label is an important aspect of this project. Using this approach, I identified that a 90 amino acid domain with the label at position 1134 was optimal. Kinetic analysis of ligand binding showed SaBPL had a Km for biotin at 3.29 ± 0.37 μM and Km for MgATP at 66 ± 16.08 μM. This was in good agreement with data obtained from our previous assay measuring ³H-biotin incorporation. Inhibitor studies with pyrophosphate and analogues of biotin and biotinyl-5'-AMP further validated the assay. Various studies have shown cross-species biotinylation activities by a diverse range of BPLs. Therefore, using this methodology with a biotin domain as the substrate potentially provides a convenient assay for all BPLs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1374330 / Thesis (M.Sc.) -- University of Adelaide, School of Molecular and Biomedical Science, 2009

Thesis (Ph. D.)--Ohio State University, 2007. / Title from first page of PDF file. Includes bibliographical references (p. 154-175).

Stuttgart, Univ., Diss., 2002.

Stuttgart, Univ., Diss., 2005.

Thesis (M.S.)--Oregon State University, 2011. / Printout. Includes bibliographical references (leaves 58-59). Also available on the World Wide Web.

Freie University, Diss., 2004--Berlin.

Universiẗat, Diss., 2004--Düsseldorf.

Στην εποχή της συστημικής βιολογίας, οι υψηλής απόδοσης (-ομικές) τεχνικές βιομοριακής ανάλυσης επέτρεψαν την ολιστική ανάλυση των διαφόρων μοριακών επιπέδων κυτταρικής λειτουργίας μέσω της ταυτόχρονης μέτρησης εκατοντάδων έως χιλιάδων αντιπροσωπευτικών μοριακών ποσοτήτων. Η μεταβολομική αναφέρεται στην ποσοτικοποίηση του (σχετικού) προτύπου συγκέντρωσης των ελεύθερων μικρών μεταβολιτών. Λαμβάνοντας υπ’ όψιν, το ρόλο των μεταβολιτών ως, αντιδρώντα ή/και προϊόντα των μεταβολικών αντιδράσεων, το πρότυπο συγκέντρωσης τους επηρεάζει και επηρεάζεται από την κατανομή των μεταβολικών ροών, αποτελώντας επομένως ένα αποτύπωμα της μεταβολικής κατάστασης ενός βιολογικού συστήματος. Μεταξύ των πλεονεκτημάτων της μεταβολομικής ανάλυσης είναι ότι μπορεί να χρησιμοποιηθεί σε μεταβαλλόμενη κατάσταση φυσιολογίας, ενώ δεν απαιτεί ολοκληρωμένη γνώση του μεταβολικού δικτύου ενός οργανισμού. Αυτά τα χαρακτηριστικά είναι ιδιαίτερα πλεονεκτικά για τη μελέτη της μεταβολικής ενεργότητας του εγκεφάλου, λαμβάνοντας υπ’όψιν την ανατομική, μορφολογική και φαινοτυπική πολυπλοκότητα αυτού του οργάνου και την έως τώρα κατανόηση των μεταβολικών του μηχανισμών. Πιο συγκεκριμένα για την επίδραση του ενήλικου υποθυρεοειδισμού στον μεταβολισμό του εγκεφάλου, η μέχρι σήμερα γνώση παραμένει αποσπασματική, ενώ προέρχεται από διαφορετικά πειράματα και διάφορες εγκεφαλικές περιοχές. Μια ολιστική θεώρηση του μεταβολισμού σε συνθήκες υποθυρεοειδισμού σε συγκεκριμένες εγκεφαλικές περιοχές αναμένεται να αυξήσει σημαντικά τη γνώση μας για την ασθένεια αυτή. Σε μια πρόσφατη μελέτη της ερευνητικής μας ομάδας, που ήταν η πρώτη μεταβολική ανάλυση εγκεφαλικού ιστού σε ζωικό μοντέλο μακρόχρονου υποθυρεοειδισμού, η πολυπαραμετρική στατιστική ανάλυση των μεταβολικών προτύπων της παρεγκεφαλίδας μυός έδειξε διαφορές στη μεταβολική φυσιολογία του ιστού στα ευ- σε σχέση με τα υποθυρεοειδικά ζώα, παρέχοντας ισχυρές ενδείξεις ότι ο μεταβολισμός της παρεγκεφαλίδας θηλαστικών επηρρεάζεται από τον μακρόχρονο υποθυρεοειδισμό. Στην παρούσα εργασία, συγκρίθηκε η επίδραση του μακρόχρονου υποθυρεοειδισμού στη μεταβολική φυσιολογία της παρεγκεφαλίδας μεταξύ αρσενικών και θηλυκών Balb/cJ μυών, αφού επεκτάθηκε για επιπλέον μεταβολίτες η αυτοματοποιημένη μέθοδος προσδιορισμού κορυφών στο χρωματογράφημα. Ο μακρόχρονος υποθυρεοειδισμός επήχθη με χορήγηση 1% υπερχλωρικού καλλίου για 64 μέρες στο πόσιμο νερό των ζώων. Αυτή είναι και η πρώτη μελέτη της επίδρασης του ενήλικου υποθυρεοειδισμού στην μεταβολομική φυσιολογία του 4 εγκεφάλου των θηλυκών μυών. Τα μεταβολικά πρότυπα αναλύθηκαν με το λογισμικό ανοικτού κώδικα ΤΜ4/ MEV(www.tm4.org/MEV) για την πολυπαραμετρική στατιστική ανάλυση των -ομικών δεδομένων. Τα αποτελέσματα συζητήθηκαν στο πλαίσιο ενός κατάλληλα ανακατασκευασμένου μεταβολικού δικτύου για την παρεγκεφαλίδα μυός με βάση τις μεταβολικές βάσεις δεδομένων KEGG και EXPASY και δεδομένα από τη βιβλιογραφία. Η ανάλυση των προτύπων έδειξε ότι η επίδραση της δίμηνης χορήγησης υπερχλωρικού καλλίου στη μεταβολική φυσιολογία της παρεγκεφαλίδας ήταν πιο οξεία στα αρσενικά απ’ότι στα θηλυκά ζώα. Αυτή η παρατήρηση υποστηριζόταν και απο την σημαντικά μικρότερη μείωση του μέσου βάρους των υποθυρεοειδικών σε σχέση με αυτό των ευθυρεοειδικών ζώων στο τέλος της δίμηνης χορήγησης στα θηλυκά σε σχέση με τα αρσενικά. Τέος, σύγκριση των μεταβολικών προτύπων της παρεγκεφαλίδας των ευθυρεοειδικών αρσενικών και θηλυκών μυών έδειξε τους μισούς από τους μεταβολίτες στην παρεγκεφαλίδα των αρσενικών να έχουν σημαντικά μεγαλύτερη συγκέντρωση απ’ ότι στον ιστό των θηλυκών. Αυτή η παρατήρηση καταδεικνύει την ανάγκη της παρεγκεφαλίδας των θηλυκών σε μικρότερες συγκεντρώσεις ελεύθερων μικρών μεταβολιτών για την εύρυθμη λειτουργία της ως ένα πιθανό παράγοντα «προστασίας» του μεταβολισμού της από την επίδραση του μακρόχρονου ενήλικου υποθυρεοειδισμού. Καθώς η παρεγκεφαλίδα των αρσενικών χρειάζεται μεγαλύτερες ποσότητες ελεύθερων μικρών μεταβολιτών, η αναμενώμενη μείωση της συγκέντρωσης των μεταβολιτών που λαμβάνει ο εγκέφαλος μέσω του αιματοεγκεφαλικού φραγμού λόγω του υποθυρεοειδισμού θα την επηρεάσει πιο γρήγορα και πιο δραστικά από αυτή των θηλυκών. Αυτές οι σημαντικές παρατηρήσεις χρειάζονται περαιτέρω διερεύνηση μέσω κατάλληλα σχεδιασμένων αναλύσεων μεταβολομικής και φυσιολογίας και άλλων εγκεφαλικών περιοχών, συνδυάζοντας επίσης μετρήσεις των επιπέδων των θυρεοειδικών ορμονών με μεταβολομική ανάλυση του εγκεφαλικού ιστού με Υγρή Χρωματογραφία- Φασματομετρίας Μάζας, καθώς και μετρήσεις ομικών αναλύσεων από άλλα επίπεδα κυτταρικής λειτουργίας, κυρίως της πρωτεωμικής. / In the systems biology era, the high-throughput “omic” technologies have enabled the holistic analysis of the various molecular levels of cellular function through the simultaneous measurement of hundreds to thousands of relevant molecular quantities. Metabolomics refers to the quantification of the (relative) concentration profile of the free small metabolites. Taking into consideration the role of the metabolites as reactants and products of the metabolic reactions, their concentration profile affects and is affected by the metabolic pathway flux distribution. Thus, the metabolic profile provides a fingerprint of the metabolic state of a biological system. Among the advantages of the metabolomic analysis is that it can be easily used to monitor transient metabolic conditions without requiring extensive knowledge of the structure and regulation of the investigated metabolic networks. This characteristic is especially advantageous for the analysis of brain metabolism, considering the anatomical, morphological and phenotypic complexity of this organ and our current shortages in understanding its metabolic mechanisms. For the effect of adult onset hypothyroidism (AOH) on brain metabolism in particular, the current knowledge remains fragmented, concerning different experimental setups and recovered from various brain regions. A holistic view of metabolism under AOH in particular brain regions is expected to significantly enhance the current knowledge about the disease. In a recent study of our group, which was the first metabolomic analysis of brain tissue in a prolonged AOH mouse model, multivariate statistical analysis of the metabolic profiles of the mouse cerebella indicated differences in the metabolic physiology of the tissue in the eu- compared to the hypo- thyroid animals, providing strong evidence that the mammalian cerebellum is metabolically responsive to prolonged AOH. In the present work, we compared the effect of prolonged AOH on the cerebellar metabolic physiology between male and female Balb/cJ mice, after enhancing the metabolite peak identification method to include additional metabolites. The prolonged AOH was induced by a 64-day treatment with 1% potassium perchlorate in the drinking water of the animals. This is the first reported analysis of the effect of AOH on the brain metabolic physiology of female mice. The raw metabolic profiles were normalized and appropriately filtered. The normalized metabolic profiles were analyzed using the open-source TM4/MeV software (www.tm4.org/MeV) for the multivariate statistical analysis of “omic” data. The acquired results were interpreted in the context of an appropriately reconstructed metabolic network for the mouse cerebellum based on the metabolic databases, KEGG and Expasy, and a plethora of information mined from the literature. The analysis of the metabolic profiles 6 indicated that the effect of the 2-month potassium perchlorate treatment on the metabolic physiology of the cerebellum is more acute in the male with respect to the female mice. The time profile of the body weight of the female compared to the male mice indicated a significantly smaller decrease in the mean weight of the hypothyroid compared to the euthyroid mice in the female compared to the male population at the end of the KClO4 treatment, an observation that further supports the metabolic profiling results. Finally, comparison between the metabolic profiles of the euthyroid male and female cerebellum indicated a significantly higher concentration in half of the measured free metabolites in the male compared to the female animals. This indicates the “leanness” of the metabolic profile of the female cerebellum as a potential “protective” parameter to the effect of AOH on its metabolic physiology, in the sense that the expected due to AOH decrease in the concentrations of the metabolites that are transferred to the brain through the blood brain barrier may affect more the male cerebellum that requires higher levels of free metabolites for its regular activity. These significant observations are in need of further investigation through appropriately designed physiological and metabolomic studies, integrating also thyroid hormone measurements from Liquid Chromatography-MS metabolomic analysis of brain tissue as well as omic measurements from other molecular levels of cellular function, mainly from proteomics.